myoActivation® for Chronic Pain in a Marginalized Population
Longitudinal Analysis of an Innovative Non-Pharmacological Intervention for Chronic Pain in a Marginalized Population: A Prospective Pilot Study of myoActivation
1 other identifier
observational
41
1 country
1
Brief Summary
Marginalized populations are at increased risk of chronic pain, trauma and use of street drugs to manage this suffering, with the associated risk of overdoses. Non-pharmacological options to manage chronic pain are difficult for this population to access. myoActivation® is an innovative structured assessment and therapeutic approach. This study will be conducted in the Vancouver Community Pain Service and will will examine the impact of this treatment on pain outcomes, function and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 10, 2020
CompletedStudy Start
First participant enrolled
February 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2022
CompletedSeptember 16, 2025
November 1, 2022
2.5 years
February 3, 2020
September 9, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
PEG score wk 4
PEG is a validated self-report measure of (1) Pain intensity, (2) interference with Enjoyment of life, (3) interference with General activity. Each of the 3 dimensions is scored on a 0-10 scale. Total score is the average (mean) of the 3 values, minimum 0, maximum 10, lower score indicates a better outcome.
4 weeks
PEG score wk 12
PEG is a validated self-report measure of (1) Pain intensity, (2) interference with Enjoyment of life, (3) interference with General activity. Each of the 3 dimensions is scored on a 0-10 scale. Total score is the average (mean) of the 3 values, minimum 0, maximum 10, lower score indicates a better outcome.
12 weeks
PEG score wk 24
PEG is a validated self-report measure of (1) Pain intensity, (2) interference with Enjoyment of life, (3) interference with General activity. Each of the 3 dimensions is scored on a 0-10 scale. Total score is the average (mean) of the 3 values, minimum 0, maximum 10, lower score indicates a better outcome.
24 weeks
Secondary Outcomes (9)
PCS score wk 4
4 weeks
PCS score wk 12
12 weeks
PCS score wk 24
24 weeks
PSEQ score wk 4
4 weeks
PSEQ score wk 12
12 weeks
- +4 more secondary outcomes
Study Arms (1)
myoActivation and other pain services
Participants who receive one or more sessions of myoActivation. They may receive 1:1 counselling and physiotherapy also.
Interventions
myoActivation is a novel, structured assessment and non-pharmacological therapeutic approach to both diagnosis and treatment of chronic myofascial pain. A detailed history of the timeline of lifetime trauma combined with a quick, structured and reproducible set of posture and movement tests help to easily identify myofascial components of chronic pain. The therapeutic component is delivered utilizing a needling technique, or myofascial release, focused to active myofascial trigger points, fascia in tension and tethered scars.
Eligibility Criteria
Structurally vulnerable persons (i.e. within marginalized populations) with chronic pain, and typically also mental health issues, substance use disorders, physical and emotional trauma.
You may qualify if:
- Any English-speaking patient with myofascial related chronic pain lasting \>3 months, referred to the Vancouver Community (VC) chronic pain service by primary care.
You may not qualify if:
- Any patient who has received any of the following pain interventions or treatment in the 3 months preceding recruitment/intake to the pain service:
- Intramuscular Stimulation (IMS);
- Trigger Point Injection (TPI) with or without injectate;
- External physiotherapy (i.e. outside the service offered at VC pain clinic);
- Massage;
- Joint injection;
- Chiropractic;
- Acupuncture;
- Group counselling at VC Pain Service (or has an existing appointment to attend Group counselling).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vancouver Community Pain Service, 524 East Pender Street
Vancouver, British Columbia, V6A 1V3, Canada
Related Publications (1)
Nguyen L, Eddy BL, West N, Bone JN, Currie LM, Lauder G. The Impact of a Novel Methodological Process for Needling Scars, Fascia, and Muscles in the Management of Myofascial Dysfunction and Chronic Pain in a Population Living With Social and Health Inequities: Quantitative Findings From a Longitudinal Observational Pilot Study. Pain Res Manag. 2025 Sep 28;2025:8567447. doi: 10.1155/prm/8567447. eCollection 2025.
PMID: 41058955DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Eddy
Vancouver Coastal Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Member in the UBC Department of Medicine, Division of Palliative Care
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 10, 2020
Study Start
February 18, 2020
Primary Completion
August 2, 2022
Study Completion
August 2, 2022
Last Updated
September 16, 2025
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share